Given there are serious limitations to pharmaceutical cannabinoid medications, it’s clear that the problem lies in the insurance system that has yet to evolve alongside patients’ needs and medical science. There is a clear disconnect when insurance companies can cover synthetic cannabinoid drugs but can’t acknowledge the medicinal value of whole cannabis compounds. Then again, the issue circles back to the federal government.
The industry’s attention still gravitates toward the legacy states. But through operators like SWADE Cannabis…
Metro Boomin and Action Bronson are headlining Puffcon in October, and that alone is worth…
Mary Jane Berlin brought tens of thousands of people into one building and reminded them…
Sacha Baron Cohen has reportedly been filming a new Ali G movie in secret. Could…
Big news for wellness enthusiasts: Canna River, the family-run brand that’s spent years earning trust…
Let's start with the headline nobody in Washington wants to print: marijuana is still illegal.…